BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8423907)

  • 1. Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Stroke Prevention in Atrial Fibrillation Investigators.
    Miller VT; Rothrock JF; Pearce LA; Feinberg WM; Hart RG; Anderson DC
    Neurology; 1993 Jan; 43(1):32-6. PubMed ID: 8423907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies.
    Hart RG; Pearce LA; Miller VT; Anderson DC; Rothrock JF; Albers GW; Nasco E
    Cerebrovasc Dis; 2000; 10(1):39-43. PubMed ID: 10629345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.
    Miller VT; Pearce LA; Feinberg WM; Rothrock JF; Anderson DC; Hart RG
    Neurology; 1996 Jan; 46(1):238-40. PubMed ID: 8559383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.
    Hart RG; Pearce LA; McBride R; Rothbart RM; Asinger RW
    Stroke; 1999 Jun; 30(6):1223-9. PubMed ID: 10356104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from the Stroke Prevention in Atrial Fibrillation trials.
    Hart RG; Halperin JL; Pearce LA; Anderson DC; Kronmal RA; McBride R; Nasco E; Sherman DG; Talbert RL; Marler JR;
    Ann Intern Med; 2003 May; 138(10):831-8. PubMed ID: 12755555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke prevention in atrial fibrillation.
    Halperin JL; Rothlauf EB
    Mt Sinai J Med; 1993 Sep; 60(4):289-94. PubMed ID: 8232372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study.
    Singer DE; Hughes RA; Gress DR; Sheehan MA; Oertel LB; Maraventano SW; Blewett DR; Rosner B; Kistler JP
    Am Heart J; 1992 Dec; 124(6):1567-73. PubMed ID: 1462916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.
    Lancet; 1994 Mar; 343(8899):687-91. PubMed ID: 7907677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing stroke in patients with nonrheumatic atrial fibrillation.
    Nelson KM; Talbert RL
    Am J Hosp Pharm; 1994 May; 51(9):1175-83. PubMed ID: 8042636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke Prevention in Atrial Fibrillation Study. Final results.
    Circulation; 1991 Aug; 84(2):527-39. PubMed ID: 1860198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain natriuretic peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillation.
    Naya T; Yukiiri K; Hosomi N; Takahashi T; Ohkita H; Mukai M; Koziol JA; Kohno M
    Cerebrovasc Dis; 2008; 26(4):434-40. PubMed ID: 18799875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.
    JAMA; 1998 Apr 22-29; 279(16):1273-7. PubMed ID: 9565007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation.
    Pearce LA; Hart RG; Halperin JL
    Am J Med; 2000 Jul; 109(1):45-51. PubMed ID: 10936477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial.
    Pullicino PM; Thompson JL; Sacco RL; Sanford AR; Qian M; Teerlink JR; Haddad H; Diek M; Freudenberger RS; Labovitz AJ; Di Tullio MR; Lok DJ; Ponikowski P; Anker SD; Graham S; Mann DL; Mohr JP; Homma S;
    Cerebrovasc Dis; 2013; 36(1):74-8. PubMed ID: 23921215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy in atrial fibrillation.
    Turpie AG; Connolly SJ
    Can Fam Physician; 1996 Jul; 42():1341-5. PubMed ID: 8754703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing stroke in patients with atrial fibrillation.
    Ezekowitz MD; Levine JA
    JAMA; 1999 May; 281(19):1830-5. PubMed ID: 10340371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress report of the Stroke Prevention in Atrial Fibrillation Study.
    Anderson DC
    Stroke; 1990 Nov; 21(11 Suppl):III12-7. PubMed ID: 2237968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation and stroke. Three new studies, three remaining questions.
    Albers GW
    Arch Intern Med; 1994 Jul; 154(13):1443-8. PubMed ID: 8017999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atrial fibrillation and apoplexy--risks and prevention].
    Koefoed BG; Gulløv AL; Petersen P
    Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.